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James E Truscott1†, T Déirdre Hollingsworth2,3,4*†, Simon J Brooker5,6 and Roy M Anderson1Abstract
Background: Amongst the world’s poorest populations, availability of anthelmintic treatments for the control of
soil transmitted helminths (STH) by mass or targeted chemotherapy has increased dramatically in recent years.
However, the design of community based treatment programmes to achieve the greatest impact on transmission is
still open to debate. Questions include: who should be treated, how often should they be treated, how long should
treatment be continued for?
Methods: Simulation and analysis of a dynamic transmission model and novel data analyses suggest refinements
of the World Health Organization guidelines for the community based treatment of STH.
Results: This analysis shows that treatment levels and frequency must be much higher, and the breadth of coverage
across age classes broader than is typically the current practice, if transmission is to be interrupted by mass
chemotherapy alone.
Conclusions: When planning interventions to reduce transmission, rather than purely to reduce morbidity, current
school-based interventions are unlikely to be enough to achieve the desired results.
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Amongst the world’s poorest populations, funding for
the control of soil transmitted helminths (STH) by mass
or targeted chemotherapy has increased steadily in the
past 10 years due to generous donations from international
aid agencies in the richer countries, philanthropic organisa-
tions and pharmaceutical companies [1]. Stimulated by the
World Health Organisation’s (WHO) 2020 Roadmap on
the control of the Neglected Tropical Diseases (NTDs), the
spirit of this expanded effort is captured in the London
Declaration in January 2012 and the progress report
one year later [2-4]. Many questions remain, however,
about how best to deliver community based treatment
programmes for STH infections to obtain the greatest
impact. These include the following: who should be
treated, how often should they be treated, how long
should treatment be continued for, can treatment intervals
be increased as worm loads fall, and can transmission* Correspondence: deirdre.hollingsworth@warwick.ac.uk
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unless otherwise stated.be eliminated by repeated chemotherapy alone? [5,6].
To answer these questions, a detailed understanding of
the transmission dynamics of the parasites is required.
Current guidelines for population-based treatment for
STH infections focus on the treatment of pre-school-aged
children (pre-SAC) between the ages of 2 to 4 years of age
and school-aged children (SAC) between the ages of 5 to
14 years [7,8], due to measured health benefits and the
low cost and simplicity of child health days and school
health programmes used to deliver treatment [9,10]. The
impact of increased funding on coverage in these age
groups is illustrated in Figure 1, which shows high cover-
age amongst pre-school-aged children increasing coverage
amongst school-aged children. The design and evaluation
of many control programmes is based on measures of
the prevalence (fraction infected [11,12]) and intensity
of infection (worm loads or parasite egg concentrations
in human faeces as a surrogate of worm load [13,14]). In
this paper, we use a mathematical model to investigate
the possibility of local elimination of parasites within a
community by regular chemotherapeutic interventions and
its dependence on the underlying strength of transmissionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Coverage of preventive STH chemotherapy in preschool-age children (Pre-SAC, blue) and school-age children (SAC, red), (a)
internationally and (b) WHO African Region, calculated by WHO as the proportion of the total population of pre-SAC and SAC living in
all the endemic areas in a country which require preventive chemotherapy for STH by year, 2003–2011 [1].
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pre-SAC, SAC and adults.
Methods
The mathematical model used describes the evolution
of the parasite distribution in different host age groups
and the impact of periodic chemotherapy on host burdens,
incorporating the key epidemiological and biological
processes influencing transmission. Building on past
research [15,16], it includes the observed features of
sexual reproduction by the dioecious helminths, heterogen-
eity in exposure to infection by host age, variation in the
intensity of transmission in different human communities,
aggregated distributions of worm numbers per host and
a decline in fecundity as a function of worm burden
(density dependence) [16-18]. The dynamics of transmis-
sion under repeated rounds of treatment is examined for
the three main intestinal nematodes, Ascaris lumbricoides,
Trichuris trichuria and hookworms (Necator americanus
and Ancylostoma duodenale). The model is described in
detail in the Additional file 1 available online.
Although a full age distribution is embedded in the
model, we employ the key age groupings described above
to define intervention coverage levels and illustrate their
effect. These are infants (0–1 years of age) who cannot be
treated under current licensure of the main anthelmintic
drugs in wide use (e.g. albendazole and mebendazole),
pre-school aged children (pre-SAC, 2–4 years of age),
school aged children (SAC, 5–14 years of age) and adults
(15+ years of age). Varying combinations of the fraction
treated in each age grouping, treatment frequency and
duration of treatment are explored. The fraction in each
grouping effectively treated is a product of the fraction
given treatment and drug efficacy (defined as the propor-
tion of worms expelled). Within the current model, thesetwo aspects of treatment are inseparable, and coverage
of the population is represented as a proportion of
worms treated. Drug efficacy is typically in the region
of 90% or more for Ascaris and hookworms, but some-
what less for Trichuris [19-22]. It should be noted that
the fraction treated is effectively chosen at random
from the subpopulation. This model does not address
systematic non-compliance.
The life cycles of these parasites involve free living
stages that are passed in the faeces of the human host
and mature to infective stages in the external habitat
(eggs for Ascaris and Trichuris and larvae for hookworms).
The infective stages of the parasite in the environment are
represented in the model by a common pool of infectious
material. The life span of these stages is typically weeks to
months under favourable environmental conditions, and
they are excreted in very large numbers [23-26]. Although
this duration is short by comparison with adult worm life
expectancies in the human host, infectious material in
the environment acts as a reservoir which is unaffected
by chemotherapy and can play a significant role in the
dynamics of treatment. Dynamics of a range of parasites
within the host population can be represented by the same
model, with distinct parameter ranges for different species
(See Additional file 1: Table S1).
Different age groups are thought to both contribute to,
and be exposed to, this infective pool to varying degrees.
An indication of this is provided by the changes in the
intensity of infection by age; the patterns are typically
convex for Ascaris and Trichuris, but continue to rise
for hookworms as individuals age [27-29] (Figure 2).
The respective roles of age related exposure to infection
versus acquired immunity remains uncertain, but rapid
re-infection by all three parasites post treatment points
to the former as the main driver of age-intensity of
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Figure 2 Age-intensity profiles for mean intensity of infection (top row) and prevalence (%, second row) for the three major soil transmitted
helminths; Ascaris [27] (left column), Trichuris [28] (middle column) & hookworm [29] (right column). Colours indicate age-group.
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are employed to fit the model to these age related patterns
of infection, to estimate both transmission intensity (mea-
sured by the basic reproductive number R0 - the average
number of offspring produced by one female worm that
survive to reproductive maturity) and age related expos-
ure. We have endeavoured to choose typical or character-
istic infection profiles for the parasite species investigated
in the hope that our results will be broadly applicable.
Results
In the absence of regular treatment, the model exhibits
two types of stable behaviour; either the endemic state
in which the age profile of infection intensity matches
those illustrated in Figure 2, for the respective parasite,
or the parasite-free or elimination state. These two states
are separated by a ‘breakpoint’ in transmission (created
by sexual reproduction which necessitates finding a mate
of the opposite sex) close to which parasite population
growth is greatly restricted and below which the popula-
tion decays to extinction [17]. It is possible for a single
round of treatment to reduce parasite burdens in the
population to a level from which they cannot recover.
However, if a single round of treatment can reduce para-
site populations to low levels close to the breakpoint,
recovery of the parasites may be insufficient to prevent
subsequent rounds from driving the population below
the break-point. Hence, for a given frequency of treatment
and parameterization of the model, we can define critical
distributions of treatment among the host population that
will eventually lead to elimination of the parasite from the
population. Using the parameter estimates for the key
epidemiological and biological processes defined in theAdditional file 1: Table S2, treatment outcomes are
explored for a wide range of effective treatment scenarios
for the three major age groupings that can be treated
(infants cannot be treated). Three different settings are
explored, where transmission intensity is low (R0 = 2),
medium (R0 = 3) and high (R0 = 5). These stratifications
differ somewhat from WHO definitions of low, medium
and high transmission settings for reasons defined in
the Additional file 1, but related to the fact that prevalence,
the WHO favoured outcome statistic, is a poor measure
of the intensity of infection due to the highly non-linear
relationship between these two epidemiological quantities
which are drawn from aggregated distributions (variance
much bigger than the mean in value) such that large
changes in intensity may result in only small changes in
prevalence [17].
The results are presented in two formats; namely, a
three dimensional surface of the effective treatment
combinations of pre-SAC, SAC and adults that results in
crossing the critical treatment surface to extinguish para-
site transmission (values equal to or above the surface
lead to long term extinction), and time series of repeated
treatment of different proportions of the three treatment
age groupings to determine how long treatment must con-
tinue to the cessation of transmission. These are presented
in Figures 3 and 4 respectively for the two formats. The
parasite with the greatest R0 value determines the intensity,
frequency and duration of treatment required. Graphs are
for Ascaris and hookworm only, since Trichuris exhibits
very similar patterns to Ascaris in terms of its age-intensity
profile, excepting drug efficacy is somewhat lower.
A series of general conclusions emerge from these cal-
culations. Annual treatment of only school aged children
a) b) c)
d) e) f)
g) h) i)
Figure 3 The critical treatment surfaces for Ascaris (row 1: a, b, c, and 3: g, h, i) and hookworm (row 2: d, e, f). Reproductive number
R0 is 2, 3 and 5 in columns 1 (a, d, g), 2 (b, e, h) and 3 (c, f, i), respectively. In rows 1 (a, b, c) and 2 (d, e, f), treatment is yearly while in row 3 (g, h, i),
treatment is every 6 months. Model parameters as in Additional file 1: Table S2. The proportion treated effectively (proportion treated x drug
efficacy) in each age grouping (pre-SAC, SAC & Adults) must lie above the ‘critical’ surface in the 3D plots (at the plateau of 1.0 all must be treated
effectively) for eradication to occur. The colours indicate coverage in SAC.
Truscott et al. Parasites & Vectors 2014, 7:266 Page 4 of 8
http://www.parasitesandvectors.com/content/7/1/266will rarely extinguish transmission, except in very low
Ascaris and Trichuris transmission settings (R0 = 2 or less).
For example, when R0 = 2, SAC need to be treated with an
overall effectiveness better than 80% for elimination to be
achieved (Figure 3a). That is, the product of the fraction of
the SAC population covered with the efficacy of the drug
must exceed 80%. Once R0 > 2 some of either adults, pre-
SAC or both must be treated as well at high coverage levels
(Figure 3b,c,e,f). In most settings where Ascaris and/or
Trichuris are prevalent, R0 exceeds 2.5 in value [31,32].
Treating both SAC and pre-SAC, as sometimes carried out
by control programmes, with high coverage (>80%) results
in good suppression but the ‘breakpoint’ is not crossed.
Treating only SAC works even less well if the dominant
parasite is hookworm, since most infection and productionof infective stages occurs in the adults (Figures 2 and 3).
In this case, the coverage of the pre-SAC population
has almost no impact on the effect of treatment. A
large proportion (>50% of the adults must be treated to
interrupt transmission in moderate to high transmission
settings (Figure 3d,e,f). In medium and high transmission
settings, if either Ascaris or Trichuris are the most preva-
lent infections, the pre-SAC and SAC individuals appear
to contribute most to transmission (based on the MCMC
estimates of age related infection rates from age-intensity
profiles). In these circumstances pre-SAC and adults must
be treated as well as SAC with coverage dependent on the
value of R0. For very high values (e.g. R0 = 5, Figure 3c)
coverage must be above 80% for all age groupings if
treatment is annual.
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Figure 4 Numerical solutions of the model for different transmission settings (R0 of 2 (a, d), 3 (b, e) and 5 (c, f)) and yearly (a, b, c) or
twice-yearly (d, e, f) treatment with 80% treatment in Pre-SAC and SAC. The mean worm burden in Infants (black), Pre-SAC (blue), SAC (red)
and Adults (orange) is shown reducing over time. Other parameters as in Additional file 1: Table S2.
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istered every 12 months in low-medium transmission
settings and every 6 months in high transmission settings
[7,8]. The model results show that the target coverage
level can be reduced if treatment is administered more
frequently such as every 6 months. This is shown for
Ascaris in Figure 3g, where in low to medium trans-
mission settings the critical treatment threshold can be
attained by only treating SAC (at above 70% for R0 = 2
and above 90% for R0 = 3). In high settings, treatment
levels that do not trigger crossing the treatment threshold
surface will have to be sustained indefinitely to avoid a
return to pre-control levels. Increasing treatment fre-
quency (every 4 months) and/or changes in behaviour and
sanitation that restrict contamination of the environment
with infective stages (and hence lower the value of R0) will
be required if elimination of transmission is to occur.
The time span over which elimination can be achieved
is very sensitive to the details of the intervention and the
transmission settings. Figure 4 shows the response of
parasite burden in the four age categories to 80% effective
coverage for preSAC and SAC. For low values of R0, and
yearly treatment for Ascaris, the threshold can be crossed
with 10 years at high (80%) treatment coverage (Figure 4a).
For 6-monthly treatment, the time is reduced to approxi-
mately 6 years (Figure 4d). Treatment at this frequency
also allows elimination at R0 = 3. However, the process
takes longer than 20 years. As shown in Figure 3, elim-
ination is generally not possible for medium to hightransmission. Figure 4b,c,f shows that a new ‘settled’
worm burden has been reached. In general, relaxation
of treatment in overall efficacy or frequency leads to a
recovery of worm burden in the population. However,
preliminary results suggest that if repeated treatment
can bring community worm burden sufficiently close to
critical level at which elimination is inevitable, it may be
possible to relax the intervention without significant
recovery for the parasite. This phenomenon is the object
of further work.
Discussion
The surfaces shown in Figure 3 clearly show that elimin-
ation of Ascaris purely through school-based deworming
is not possible except where transmission settings are at
their lowest. Some additional coverage of pre-school
children and/or adults is also required. For hookworm,
some coverage of adults is essential. The surfaces indicate
what ranges of effective coverage will allow elimination
but not how long the process may take. As Figure 4 indi-
cates, the elimination goal may be reached in 5–6 years or
over several decades and can be very sensitive to the
details of treatment coverage and the dynamics of the
parasite in the host population.
The optimal approach to treating age groups other
than school-age children depends not only on the
epidemiological impact but also the practicality and
cost-effectiveness of alternative approaches. Perhaps
the longest running community-based helminth control
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Programme for Onchocerciasis Control (APOC), which
has helped countries create a community-directed treat-
ment (CDT) strategy involving both community-directed
drug distributors and extending and strengthening health
systems [33-36]. The CDT approach is also employed by
lymphatic filariasis (LF) control programmes in Africa
which administer albendazole and ivermectin (or diethyl-
carbamazine, DEC) to entire populations aged 2 years
and above in LF endemic areas [37]. In addition to the
role of community drug distributors, there is a potential
for community health workers to deliver treatment, as
recently demonstrated for schistosomiasis control in
western Kenya [38] and STH control in Ethiopia [39].
A randomised community evaluation in Kenya is currently
underway to evaluate the impact and cost-effectiveness of
school- versus community-based delivery of albendazole
on the transmission of STH in settings with different
levels of transmission and species mix. A qualitative evalu-
ation nested within this study will also investigate the
acceptability and feasibility of using alternative delivery
platforms.
In many poor rural areas of sub-Saharan Africa and
southeast Asia long-term commitments to frequent treat-
ment will be difficult to achieve and, as we demonstrate
here, in high transmission settings, treatment alone will
not interrupt transmission. In such settings, there is a
basic requirement to improve hygienic behaviour and
access to improved drinking water and sanitation (WASH).
The potential benefits of increased access for reducing the
risk of STH has been recently highlighted by a systematic
review of the associations between STH and water and
sanitation which found that people with access to improved
water and sanitation facilities were half as likely to be
infected with any STH species, with the strongest asso-
ciations for access to sanitation and use of soap [40].
Levels of access to improved drinking water and sanitation
varies greatly within countries [41], and understanding
the geographical inequality in access can help identify
areas where treatment can and cannot break transmission.
In areas where access is relatively high, there is a real
potential to reduce and/or interrupt transmission; in
areas where access to water and sanitation remains low,
the priority should be on increasing access. Ongoing
work is investigating the influence of access to water and
sanitation as well as other contextual and programmatic
factors on the feasibility of interrupting transmission and
mapping those areas where this might be possible.
Our model provides insight into optimal approach to
the control of STH, but our approach is not without its
limitations. There remains much uncertainty about the
nature of transmission dynamics between individuals.
While infectious contact rates can be inferred from the
baseline infection profile, little can be said about thenature of the infection process or whether a single envir-
onmental reservoir is the best model. We have chosen to
use the ‘trickle’ model of the infection process rather than
the ‘clumping’ model, primarily due to its convenience
within a deterministic model paradigm [42]. Other work
has shown that the clumping model can have a significant
impact on the model’s response to treatment and its
sensitivity to parameter values [42,43]. To resolve these
questions will require longitudinal treatment trials, record-
ing data at multiple time-points from both treated and
untreated age-groups over 3–5 years. Such trials are
currently in progress in Kenya.
Details of model structure and precise parameter values
are only important if the behaviour modelled is sensitive
to them. In the current paper, we have not included a
formal sensitivity analysis, but numerical investigations
indicate that the parameter groupings we have focused
on (worm lifespan, R0 and proportion and frequency of
effective treatment) are those to which the model is most
sensitive. The aggregation of the worms among hosts (k),
timescale of infectious material in the environment (μ2)
and population demography do not have a strong effect
on the results. We investigate assumptions around the
deposition of eggs and acquisition of infection in different
ages in a follow-up publication [44].
The current model also does not take into account sys-
tematic non-compliance with repeated treatments, which
may create a reservoir of transmission that is difficult to
reach. It is probable that certain groups are more likely to
systematically reject treatment and extra effort is required
to target these groups [45]. This phenomenon is the subject
of ongoing work.
Global STH control efforts are currently focused on
scaling up treatment coverage in school-aged children to
75%, a goal which is justified on the health and education
benefits of treating this age group and which is achievable
given current drug donation programmes and increased
funding. The achievement of this coverage goal should
remain the priority of national governments and the
international community. However, there is an additional
potential to interrupt transmission by expanding treat-
ment to additional age groups and increasing treatment
frequency in some settings. Work is underway to validate
our models with available data and to evaluate the impact
of different treatment strategies in a graded series of rando-
mised evaluations in contrasting transmission settings.
Conclusion
This modelling analysis has shown how the possibility of
breaking the parasite transmission cycle depends on the
age groups treated, the coverage and efficacy of treatment
and the species in question. Our results strongly indicate
that when planning to reduce or eliminate transmission,
rather than simply reduce morbidity, treatment of school-
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school-age children or adults is necessary, depending on
the transmission setting and worm species.
Additional file
Additional file 1: Model description and parameters including
Figure S1 Approximate relationships for soil-transmitted helminths
between prevalence (as a proportion) and the mean worm burden,
and prevalence and the basic reproductive number R0 (simple
relationship – no mating function, no age structure).
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